| HB | Hepatoblastoma |
| LXR | Liver X Receptor |
| RXR | Retinoid X Receptor |
| TRIM29 | Tripartite motif containing 29 |
| CTNNB1 | CATENIN β1 |
| IPA | Ingenuity Pathway Analysis |
| FXR | Farnesoid X Receptor |
| LBD | Ligand binding domain |
| ATDC | Ataxia-telangiectasia group D-associated protein |
| Dvl2 | Disheveled 2 |
| GSK3β | Glycogen synthase kinase 3β |
| MMP-9 | Matrix metalloproteinase 9 |
| LD50 | Lethal dose 50% |
| Rb | Retinoblastoma |
| HCC | Hepatocellular carcinoma |
| CSC | Cancer stem cell |
| DMEM | Dulbecco’s modified Eagle’s medium |
| FBS | Fetal bovine serum |
| PBS | Phosphate-buffered saline |
| RIPA | Radio-immunoprecipitation assay |
| mTOR | Mammalian target of rapamycin |
| NP40 | Nonidet P-40 |
| DMSO | Dimethyl sulfoxide |